doot on Nostr: this is still the state’s fault. here’s a similar case: pharmaceutical companies ...
this is still the state’s fault.
here’s a similar case: pharmaceutical companies get a patent for a new drug that will last for x years, and acting in their own self-interest they exploit the fact that they can extend the patent with minor modifications to the drug.
it’s a drug that could easily be produced at a low-cost by competitors.
as you’ve noted, the state doesn’t force them to extend their patents, but there’s a clear incentive for them to do this. yet in a free-market, this is not possible and competitors would make the drug.
capitalism fixes this, but the state creates the problem.
Published at
2024-08-29 09:46:18Event JSON
{
"id": "a22a91e52c2f487b1e32b5964a316cc2a1461758be6156b711f4e3b229c12f1a",
"pubkey": "8f44c56131b362668b0e01be8c71b24786598bb68fb909cfd78fabfb058dd0f0",
"created_at": 1724924778,
"kind": 1,
"tags": [
[
"e",
"43d71ee19cc211346a06fe9b5cbaea688fbfe9a6583fca9c8cdb92ef2e1db9cf",
"",
"root"
],
[
"p",
"a1915eda2be214344bfd4b24b8f02218337e3d4b788cf7aaf5a494b58c61c210"
]
],
"content": "this is still the state’s fault. \nhere’s a similar case: pharmaceutical companies get a patent for a new drug that will last for x years, and acting in their own self-interest they exploit the fact that they can extend the patent with minor modifications to the drug. \nit’s a drug that could easily be produced at a low-cost by competitors. \n\nas you’ve noted, the state doesn’t force them to extend their patents, but there’s a clear incentive for them to do this. yet in a free-market, this is not possible and competitors would make the drug.\ncapitalism fixes this, but the state creates the problem.",
"sig": "f54117c674eb9169514aa717e1d7e53feda2ff4b4c0294c03f60125a07761eeae683fe918905805a43530355570d09e05db112cb9c6e0fca4e915d7d986d9573"
}